Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification.
Van Neste L, Henao R, Wojno KJ, Signes J, DeHart J, Busta A, Marriott E, Willing M, Argentini A, Hurley PM, Korman H, Hafron J, Putzi M, Pieczonka CM, Karsh LI, Morris DS, Kassis AI, Kantoff PW.
Van Neste L, et al. Among authors: kassis ai.
J Urol. 2024 Mar;211(3):415-425. doi: 10.1097/JU.0000000000003824. Epub 2023 Dec 26.
J Urol. 2024.
PMID: 38147400